Namodenoson Shows Protective Effects Beyond Liver Cancer in Can-Fite’s Pivotal Study
Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...
Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...